VENTIZIR Trademark

Trademark Overview

On Thursday, January 20, 2011, a trademark application was filed for VENTIZIR with the United States Patent and Trademark Office. The USPTO has given the VENTIZIR trademark a serial number of 85222121. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 1, 2014. This trademark is owned by Glaxo Group Limited. The VENTIZIR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
ventizir

General Information

Serial Number85222121
Word MarkVENTIZIR
Filing DateThursday, January 20, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 1, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe word "VENTIZIR" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 25, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Tuesday, September 2, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 1, 2014ABANDONMENT - NO USE STATEMENT FILED
Friday, January 31, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 30, 2014EXTENSION 5 GRANTED
Tuesday, January 14, 2014EXTENSION 5 FILED
Tuesday, January 14, 2014TEAS EXTENSION RECEIVED
Wednesday, August 21, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 20, 2013EXTENSION 4 GRANTED
Friday, July 19, 2013EXTENSION 4 FILED
Thursday, August 15, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 19, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 23, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 22, 2013EXTENSION 3 GRANTED
Sunday, January 20, 2013EXTENSION 3 FILED
Sunday, January 20, 2013TEAS EXTENSION RECEIVED
Thursday, August 9, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 8, 2012EXTENSION 2 GRANTED
Friday, July 20, 2012EXTENSION 2 FILED
Wednesday, August 8, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 20, 2012TEAS EXTENSION RECEIVED
Wednesday, January 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 16, 2012EXTENSION 1 GRANTED
Monday, January 16, 2012EXTENSION 1 FILED
Monday, January 16, 2012TEAS EXTENSION RECEIVED
Tuesday, July 26, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 31, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2011PUBLISHED FOR OPPOSITION
Tuesday, April 19, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 14, 2011ASSIGNED TO EXAMINER
Tuesday, January 25, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 24, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

ventizir pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological